William Strohl

Bill is founder and owner of BiStro Biotech Consulting LLC. Prior to retiring from Johnson & Johnson in 2016, Dr. Strohl was VP and Head, Janssen BioTherapeutics, Janssen R&D, J&J, where he headed up biologics discovery and early development. Before that, Bill was head of Biologics Research, the discovery arm of Janssen BioTherapeutics. Before joining J&J, he was at Merck and Co, leading the Biologics discovery efforts, where he was involved in two biotechnology company acquisitions.